Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Publication year
2018
Author(s)
Hensley, Martee L.
Enserro, Danielle
Hatcher, Helen
Ottevanger, P.B.
Krarup-Hansen, Anders
Blay, Jean-Yves
Robison, Katina
Miller, David S.
Source
Journal of Clinical Oncology, 36, 33, (2018), pp. 3324-3330
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/200564   https://hdl.handle.net/2066/200564
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.